Marc F Diederich

18PUBLICATIONS
41CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsNatural products and bioactive compoundsCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 16, 2026
Histone deacetylase inhibitors as venetoclax-sensitising partners in acute myeloid leukaemia: Mechanisms, pharmacology and translational perspectives.

|Jul 01, 2026
OT-55 reshapes tolerogenic BH3-mimetic-induced apoptosis toward immunogenic cell death in acute myeloid leukemia, potentiating PD-1/Tim-3 blockade.

|Jun 25, 2025
Marine Natural Products as Anticancer Agents 3.0.

Celso Alves, Marc Diederich

|Oct 31, 2023
ATP1A1/BCL2L1 predicts the response of myelomonocytic and monocytic acute myeloid leukemia to cardiac glycosides.

Claudia Cerella, Sruthi Reddy Gajulapalli, Anne Lorant

|Jan 11, 2022
Discovery of Sulforaphane as an Inducer of Ferroptosis in U-937 Leukemia Cells: Expanding Its Anticancer Potential.

Giulia Greco, Michael Schnekenburger, Elena Catanzaro

|Aug 26, 2021
Marine Natural Products as Anticancer Agents.

Celso Alves, Marc Diederich

Pageof 3

Frequent Collaborators

3 joint publications

Michael Schnekenburger

3 joint publications

Claudia Cerella

2 joint publications

Sruthi Reddy Gajulapalli

2 joint publications

Celso Alves